[ad_1]
SAN DIEGO–(BUSINESS WIRE)–Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a number one insulin supply and diabetes expertise firm, immediately introduced new real-world insights from a survey on Tandem Mobi consumer satisfaction and wearability throughout the 84th Scientific Periods of the American Diabetes Affiliation (ADA) going down in Orlando, Florida. The survey discovered that 86 % of individuals have been happy or very happy with Tandem Mobi no matter prior remedy and agreed that Tandem Mobi helps enhance their high quality of life.1 Tandem Mobi, the world’s smallest, sturdy automated insulin supply (AID) system, turned commercially accessible in america in February of 2024.
These real-world consumer insights present proof that we’re furthering our mission to enhance the lives of individuals with diabetes by demonstrating that Tandem Mobi not solely meets, however exceeds consumer expectations, mentioned Jordan Pinsker, MD, chief medical officer at Tandem Diabetes Care (NASDAQ:). We’re proud to share these outcomes at ADA and can proceed to innovate to offer the diabetes group with selection and improved high quality of life.
Within the six-week restricted launch survey, early customers who have been beforehand utilizing a number of each day injections (MDI), different insulin pumps (tubed and tubeless), or have been earlier Tandem pump customers, additionally exhibited excessive satisfaction with the distinctive wearability options of Tandem Mobi mixed with the Management-IQ algorithm. Tandem Mobi is so small that it may be worn nearly anywhere2, giving customers better discretion, consolation, and adaptability. In the meantime, Management-IQ expertise predicts and helps stop highs and lows.3
Of prior MDI customers:
84 % say Tandem Mobi reduces the burden of managing their diabetes82 % say Tandem Mobi is straightforward to use77 % say Tandem Mobi helps them really feel they’ve extra freedom of their lives
Of prior pump customers:
78 % say Tandem Mobi reduces the burden of managing their diabetes88 % say Tandem Mobi is straightforward to use80 % say Tandem Mobi helps them really feel they’ve extra freedom of their lives
Barbara Davis Middle Examine of Early Customers
Additionally shared at ADA have been insights from an impartial research involving Tandem Mobi customers. The outcomes confirmed that point in vary improved with no enhance in time spent under vary. For youthful individuals, kind issue, portability, discreteness, and wearability are paramount to satisfaction and ongoing use. Tandem Mobi gives many choices that help the wants of youth with kind 1 diabetes, together with:
Minimal fill (30 items) – Much less insulin waste for customers with low insulin requirementsPhysical on-pump Fast Bolus button – Easy, discreet bolusing with programming in grams or unit incrementsOn-body put on with a light-weight adhesive sleeve and 5-inch tubing (every offered individually)Private, appropriate iPhone management
The product theater was recorded and can be accessible on the ADA web site following the shut of the convention for entry by registered attendees, and on the Tandem web site at tandemdiabetes.com/suppliers/occasions.
1
As of June 2024. Knowledge on file, Tandem Diabetes Care.
2
The pump shouldn’t be positioned greater than 12 inches (30.5 cm) above the infusion website. Doing so might end in over supply of insulin.
3
All revealed medical trials and real-world research of Management-IQ expertise so far are primarily based on use of Dexcom (NASDAQ:) G6 CGM with the Tandem t:slim X2 insulin pump.
About Tandem Diabetes Care
Tandem Diabetes Care, a worldwide insulin supply and diabetes expertise firm, manufactures and sells superior automated insulin supply techniques that scale back the burden of diabetes administration, whereas creating new prospects for sufferers, their family members, and healthcare suppliers. The Firm’s pump portfolio options the Tandem Mobi system and the t:slim X2 insulin pump, each of which function Management-IQ superior hybrid closed-loop expertise. Tandem Diabetes Care is predicated in San Diego, California. For extra data, go to tandemdiabetes.com.
Observe Tandem Diabetes Care on X @tandemdiabetes; use #tslimX2 #TandemMobi and #TandemDiabetes.
Observe Tandem Diabetes Care on Fb (NASDAQ:) at www.fb.com/TandemDiabetes.
Observe Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/firm/tandemdiabetes.
© 2024 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Tandem logos, Management-IQ, t:slim X2, and Tandem Mobi are logos of Tandem Diabetes Care, Inc. in america and/or different nations. All third-party marks are the property of their respective house owners.
Accountable Use of Management-IQ expertise
Management-IQ expertise doesn’t stop all highs and lows. Customers should nonetheless bolus for meals and actively handle their diabetes. Go to tandemdiabetes.com/responsible-use for extra essential security data.
Essential Security Info
RX ONLY. Indications for Use: Tandem Mobi system: The Tandem Mobi insulin pump with interoperable expertise (the pump) is meant for the subcutaneous supply of insulin, at set and variable charges, for the administration of diabetes mellitus in individuals requiring insulin. The pump is ready to reliably and securely talk with appropriate, digitally linked gadgets, together with automated insulin dosing software program, to obtain, execute, and ensure instructions from these gadgets. The pump is meant for single affected person, house use and requires a prescription. The pump is indicated to be used in people 6 years of age and better. t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable expertise is meant for the subcutaneous supply of insulin, at set and variable charges, for the administration of diabetes mellitus in folks requiring insulin. The pump is ready to reliably and securely talk with appropriate, digitally linked gadgets, together with automated insulin dosing software program, to obtain, execute, and ensure instructions from these gadgets. The pump is meant for single affected person use. The pump is indicated to be used with NovoLog or Humalog U-100 insulin. The pump is indicated to be used in people 6 years of age and better. Management-IQ expertise: Management-IQ expertise is meant to be used with appropriate built-in steady glucose displays (iCGM, offered individually) and alternate controller enabled (ACE) pumps to mechanically enhance, lower, and droop supply of basal insulin primarily based on iCGM readings and predicted glucose values. It may well additionally ship correction boluses when the glucose worth is predicted to exceed a predefined threshold. Management-IQ expertise is meant for the administration of Sort 1 diabetes mellitus in individuals 6 years of age and better. Management-IQ expertise is meant for single affected person use. Management-IQ expertise is indicated to be used with NovoLog or Humalog U-100 insulin.
WARNING: Management-IQ expertise shouldn’t be utilized by anybody underneath the age of 6 years previous. It must also not be utilized in sufferers who require lower than 10 items of insulin per day or who weigh lower than 55 kilos.
Management-IQ expertise just isn’t indicated to be used in pregnant ladies, folks on dialysis, or critically sick sufferers. Don’t use Management-IQ expertise if utilizing hydroxyurea. Customers of a Tandem insulin pump and Management-IQ expertise should use the insulin pump, CGM, and all different system parts in accordance with their respective directions to be used; check blood glucose ranges as really helpful by their healthcare supplier; reveal satisfactory carb-counting expertise; keep adequate diabetes self-care expertise; see healthcare supplier(s) usually; and have satisfactory imaginative and prescient and/or listening to to acknowledge all capabilities of the pump, together with alerts, alarms, and reminders. The Tandem pump and the CGM transmitter and sensor should be eliminated earlier than MRI, CT, or diathermy remedy. Go to tandemdiabetes.com/safetyinfo for extra essential security data.
View supply model on businesswire.com: https://www.businesswire.com/information/house/20240622672597/en/
Media Contact:858-366-6900media@tandemdiabetes.com
Investor Contact:858-366-6900IR@tandemdiabetes.com
Supply: Tandem Diabetes Care, Inc.
[ad_2]
Source link
